Predicting and Preventing Adverse Maternal and Child Outcomes of Opioid Use Disorder in Pregnancy
Key facts
- Who runs it
- Ilana Hull
- Where
- Pittsburgh, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 28 Aug 2023
- Expected to end
- 1 Dec 2026
- Type of study
- Observational
- Treatments tested
- Buprenorphine/ Methadone exposure
- Record updated
- 6 August 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women only
- Healthy volunteers
- Cannot take part
Show the full registry criteria (10)Hide the full registry criteria
Who can take part
- Pregnant women with OUD and their infant
- Currently on BUP/METH for OUD
- Enrolled in prenatal opioid maintenance program
- Age >18 years
- Singleton pregnancy
- Planned delivery at UPMC's Magee Womans Hospital
- Positive opioid urine screen results
Who cannot take part
- Serious maternal medical illness as deemed by the PI that would make it challenging to comply with study procedures
- HIV or AIDS
- Known major fetal congenital abnormalities
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Sex
- Opioid use disorder or pregnancy related
This trial is currently available in United States.
- UPMC-Magee Womens HospitalPittsburgh, United StatesContact: Ilana Hull, MDTaking people
About the trial
What the trial wants to find out
This study will be a 12-month prospective, genotype-blinded longitudinal observational study with current standard of clinical care. This study will enroll 100 pregnant women with OUD at UPMC Hospitals with its high volumes. Because of the observational nature of the study, the anticipated dropout rate will be ≤ 20%. Investigators expect the effective sample size of evaluable patients will be 200 with longitudinal data.
The group in the trial
- Pregnant women with Opioid Use Disorder (OUD)
This study will enroll 100 pregnant women with OUD at UPMC with its high volumes
Treatment: Buprenorphine/ Methadone exposure
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 3 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT05942313, who can take part
- Record updated
- 6 August 2026